Ovarian cancer is the most lethal gynecological malignancy because of its poor prognosis. The Warburg effect is one of the key mechanisms mediating cancer progression. Molecules targeting the Warburg effect are therefore of significant therapeutic value for the treatment of cancers. Many microRNAs (miR) are dysregulated in cancers, and aberrant miR expression patterns have been suggested to correlate with the Warburg effect in cancer cells. In our study, we found that miR-145 negatively 
DNA methylation is a major epigenetic rule controlling chromosomal stability and gene expression, 8, 9 which is controlled by DNA methyltransferases (DNMT). DNMT3A and DNMT3B are responsible for de novo methylation in the genome, 10 whereas DNMT1 is responsible for maintaining methylation in the genome. DNMT3A and DNMT3B
have been reported to be upregulated in ovarian cancers. 11 They are both able to hypermethylate the promoter region in microRNA (miR)
precursor genes and thus inversely regulate miR transcription. 9 miR are small, noncoding RNAs that modulate gene expression at the post-transcriptional level through complementary binding to the 3′UTRs of target mRNAs. 12 miR-145 is shown to be downregulated in many cancers; [13] [14] [15] [16] [17] [18] it functions as a tumor suppressor to inhibit tumor cell growth and survival, induce cell apoptosis and cell cycle arrest, and attenuate tumor cell migration and invasion by targeting various molecules. [14] [15] [16] [19] [20] [21] [22] In our study, we found that miR-145 inhibited aerobic glycolysis through directly targeting HK2. Using
MethPrimer (http://www.urogene.org/methprimer/), we predicted that there were many methylations of CpG islands in the 5′ regulatory region of miR-145-5p. We propose that miR-145 expression is regulated by methylation.
Until now, the role of DNMT3A in cancer has been less studied than that of DNMT3B. Reports have shown that DNMT3A deficiency promotes tumor growth and progression. 10 However, few studies have been carried out to elaborate the role of DNMT3A in the Warburg effect. Herein, we report the interaction between miR-145 and DNMT3A and its underlying molecular mechanism in the Warburg effect in ovarian cancer cells in order to broaden our theoretical understanding of human ovarian cancer and to provide novel possibilities for future EOC treatment approaches.
| MATERIALS AND METHODS

| Human tissue specimens
Human ovarian carcinomas and normal ovarian tissue samples were collected from patients at The First Affiliated Hospital of Xi'an Jiaotong University, China. This study was approved by the Ethics Committee of The First Affiliated Hospital of Xi'an Jiaotong University, China. Written consent was obtained from each study participant enrolled. Clinicopathological characteristics of the informative cases are shown in Table 1 .
| Cell culture and treatment with 5-aza-2′-deoxycytidine
The human ovarian cancer cell line SKOV3 was obtained from the 
| Quantitative real-time PCR
Total RNA was extracted from cells using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. For mRNA detection, first-strand cDNA was synthesized using a RevertAid first-strand cDNA synthesis Kit (Thermo Fisher Scientific Inc.,
Waltham, MA, USA). qRT-PCR was carried out using a SYBR Premix
Ex Taq II kit (Takara, Dalian, China) on a CFX96 real-time PCR system (Bio-Rad, Hercules, CA, USA). miR-145 was normalized to small nuclear U6, whereas HK2, LDH, PKM2, PFK2, PDK1 and DNMT3A
were normalized to the gene β-actin. Relative gene expression was calculated automatically using 2
−ΔΔCt
. The following primer sequences were used.
DNMT3A forward: 5′-TATTGATGAGCGCACAAGAGAGC-3′;
DNMT3A reverse: 5′-GGGTGTTCCAGGGTAACATTGAG-3′;
HK2 forward: 5′-AAGGCTTCAAGGCATCTG-3′;
HK2 reverse: 5′ -CCACAGGTCATCATAGTTCC-3′;
LDH forward: 5′-GGCCTGTGCCATCAGTATCT-3′;
LDH reverse: 5′-GGAGATCCATCATCTCTCCC-3′;
PKM2 forward: 5′-TCCGGATCTCTTCGTCTTTG-3′;
PKM2 reverse: 5′-GTCTGAATGAAGGCAGTCCC-3′;
PFK2 forward: 5′-GCTATGAAACCAAAACCCCA-3′;
PFK2 reverse: 5′-TAACGATCAGAGTCGGGGAG-3′;
PDK1 forward: 5′-CAACAGAGGTGTTTACCCCC-3′;
PDK1 reverse: 5′-ATTTTCCTCAAAGGAACGCC-3′;
β-actin forward: 5′-TCCCTGGAGAAGAGCTACGA-3′;
β-actin reverse: 5′-AGCACTGTGTTGGCGTACAG-3′. 
| Western blot
| Small interfering RNA and transient transfection
Human DNMT3A siRNA was purchased from GenePharma (Shanghai, China). Ovarian cancer cells were seeded into 6-well plates until they reached 40%-50% confluency. DNMT3A siRNA (CAGUGGU-GUGUGUUGAGAATT) was transiently transfected 100 nmol/L per well using the X-treme GENE siRNA Transfection Reagent (Roche).
After 48 hours transfection, the cells were harvested for further studies.
| Micro RNA transient transfection
Micro RNA-145 mimic and negative control were purchased from RiboBio Co. Ltd (Guangzhou, China). SKOV3 and 3AO cells were transiently transfected with 60 nmol/L miR-145 mimic or negative control using the X-treme GENE siRNA Transfection Reagent (Roche)
following the manufacturer's protocol.
| Glucose consumption and lactate production assay
To determine the levels of glucose and lactate, supernatants of cell culture media were collected and detected using a glucose and lactate assay kit (BioVision, Milpitas, CA, USA) according to the manufacturer's instructions. Glucose consumption and lactate production were calculated based on the standard curve and normalized to the cell number. 
| Luciferase reporter plasmid construction
Wild-type 3′-UTR sequences of the target genes carrying a putative miR-145 binding site were amplified by PCR. To generate mutant 3′-UTR fragments of miR-145 target genes, we adopted the two-step PCR method as reported previously. Briefly, two fragments of 3′-UTR were amplified by two sets of overlapped primers in which mutated seeding sequences of miR-145 were introduced. The wildtype and mutant PCR products were digested with HindIII and MIuI enzymes, inserted into pMIR-REPORT Luciferase vectors (Ambion, Austin, TX, USA) and verified by DNA sequencing.
| Luciferase reporter assay
Cells were cotransfected with pRL-TK vector (20 ng), wild-type (WT-3′ UTR) or mutant (MUT-3′ UTR) reporter vectors (180 ng), along with miR-145 mimic or negative control at a final concentration of 20 nmol/L using the X-treme GENE siRNA Transfection Reagent.
Twenty-four hours after transfection, relative firefly luciferase activity (normalized to Renilla luciferase activity) was measured using a dual-luciferase reporter gene assay system (Promega, Madison, WI, USA), and results were depicted as the percentage change over the respective control.
| Coimmunoprecipitation
Coimmunoprecipitation (co-IP) assays were carried out using Pierce crosslink immunoprecipitation kits (Cell Signaling, San Jose, CA, USA)
according to the manufacturer's instructions. Cells were treated with 1 mL extraction buffer (10 mmol/L HEPES, pH 7.5, 100 mmol/L NaCl, 1 mmol/L EDTA, 10% Glycerol, 0.5% Triton X-100 and 5 μmol/L MG132). Co-IP procedures were carried out at 4°C unless otherwise indicated, using a Pierce spin column which can be capped and plugged with a bottom plug for incubation or unplugged to remove the supernatant by centrifugation at 1000 g for 1 minute. Binding of the first antibody to protein A/G agarose was carried out with the protocol described in Pierce crosslink immunoprecipitation kits (Thermo Scientific, Rockford, IL, USA) with slight modification. For the co-IP experiment without using disuccinimidyl suberate (DSS) cross-linking, protein A/G agarose was incubated with anti-DNMT3A antibody at 25°C for 1 hour on a mixer, followed by incubation with 600 μL precleared lysate overnight. The immunoprecipitated products were washed with washing buffer five times and eluted with 2× Laemmli buffer at 100°C
for 10 minutes. The cap of the spin column was loose to avoid overpressure and leakage from the bottom when boiling. The eluting complex was subjected to SDS-PAGE separation for western blot.
| Immunohistochemistry analysis
Paraffin-embedded tissue sections on poly-L-lysine-coated slides were 
| Statistical analysis
All experiments were carried out in triplicate at least, and each experiment was independently done at least three times. Graphical presentations were done using GraphPad Prism 5.0. Data are presented as means ± SE and were analyzed using SPSS 22.0 software (SPSS, Chicago, IL, USA). Statistical differences were tested by chisquared test, two-tailed t test, one-way ANOVA test, or Fisher's exact test. Differences were considered significant at P < .05 (*) or highly significant at P < .001 (**). Figure 1A ), but DNMT3A level in ovarian cancer tissue samples was higher than in normal ovarian tissue samples ( Figure 1C ). Moreover, we found that miR-145 level was inversely asso- Figure 3C ) and decreased the methylation levels of promoter regions in the miR-145 precursor gene ( Figure 3E ). Ectopic expression of DNMT3A ( Figure 3F,H) repressed miR-145 ( Figure 3G ) and elevated methylation levels in and 3AO cells expressing either control or mimic145 were cultured for 48 h. Acidification of the culture medium was evaluated by visually inspecting the color of the medium. C, Levels of lactate in the culture medium and glucose consumption were then measured and normalized to cell number. D, Quantitative real-time PCR analysis shows that expression of metabolic enzyme genes was downregulated in SKOV3 and 3AO cells treated with mimic145 for 48 h. E, Western blot assays show that expression of HK2 was downregulated in SKOV3 and 3AO cells treated with mimic145 for 72 h. F, Luciferase reporter assays show that miR-145 targeted HK2 directly. G, Western blot assays show that overexpression of HK2 counteracted the decline of HK2 caused by miR-145 overexpression. H, Levels of lactate in the culture medium and glucose consumption were reduced by miR-145 overexpression, and the effect was attenuated by overexpression of miR-145 and HK2. *P < .05, **P < .01, t test. GLUT1, glucose transporter 1; LDH, lactate dehydrogenase; PDK1, pyruvate dehydrogenase kinase; PFK2, phosphofructokinase 2; PKM2, pyruvate kinase M2 the promoters of miR-145 precursor genes ( Figure 3I ) in EOC cells.
These data demonstrate that DNMT3A downregulated miR-145 by maintaining high levels of methylation in the promoter regions of miR-145 precursor genes.
| Micro RNA-145 directly inhibited DNMT3A
We also investigated the possible effect of miR-145 on DNMT3A expression and found that overexpression of miR-145 inhibited DNMT3A expression in EOC cells ( Figure 4A,B) . Next, we predicted 
| Expression of HK2 and DNMT3A in ovarian cancer tissue subcutaneous tumors of nude mice
In preliminary studies, we found that miR-145 inhibited growth of xenografts of ovarian cancer in nude mice. 23 Here, to further investi- Increasing evidence has shown that these DNMT work together to maintain a normal methylation pattern, and deregulation of either one could promote malignancies. 27 More recently, DNMT3A has been reported to participate in epithelial-mesenchymal transition (EMT). [28] [29] [30] In the present study, we showed for the first time that DNMT3A promoted the Warburg effect. Here, DNMT3A alone was found not only to increase HK2, but also to promote the expression of PKM2; glucose consumption and lactate production were accordingly promoted. DNMT3A can therefore be considered a promotor of the Warburg effect. The mediators of DNMT3A and PKM2 required identification in order to establish the functional network of DNMT3A.
Micro RNA-145 has been shown to be involved in tumor invasion and progression by targeting c-Myc, astrocyte elevated gene-1 (AEG-1), epidermal growth factor receptor (EGFR), nucleoside diphosphate linked moiety X-type motif 1 (NUDT1), and octamer-binding transcription factor 4 (OCT4) in lung adenocarcinoma (LAC) 16, 31, 32 and has been acknowledged as a putative tumor-suppressor miRNA.
Previously, one study reported that miR-145 clustered with miR-143 to directly regulate HK-2 in renal cell carcinoma. 33 Here, miR-145 alone was found not only to repress HK2, but also to indirectly attenuate expression of PKM2 and LDH; glucose consumption and lactate production were accordingly weakened. MiR-145 can therefore be considered a repressor of the Warburg effect. In terms of the regulation of PKM2 by miR-145, as no seeding sequence of miR-145 was predicted in the 3′-UTR of the PKM2 gene, PKM2 was considered to be indirectly regulated by miR-145. In liver cancer cells, miR-145 abolished insulin-induced PKM2 expression; however, the interaction between miR-145 and PKM2 was not determined. 34 Recent studies have shown that miR-145 perturbed the Warburg effect by suppressing the pathway of KLF4/PTBP1/PKM in bladder cancer cells. 35 The downstream mechanisms of miR-145 that alter cellular processes have been partially confirmed in several published studies. In comparison, the upstream mechanism by which miR-145 is downregulated in EOC remains less well understood. Recently, epigenetic silencing of tumor-suppressor miRNA by aberrant DNA hypermethylation has received increasing attention for a variety of cancers. 16, 31, 32, 36 To explore the epigenetic mechanism regulating miR-145 in EOC, we compared the expression of miR-145 in SKOV3
and 3AO cell lines before and after treatment with 5-Aza-CdR. We identified that miR-145 expression was regulated by methylation. In our study, we found miR-145 inhibited the Warburg effect by targeting DNMT3A and HK2. Of note, DNMT3A did not interact with HK2. These results show that DNMT3A regulated HK2 expression by miR-145.
In a previous study, we indicated that 20(S)-Rg3 blocked EMT through DNMT3A/miR-145/FSCN1 pathways. 23 We studied the regulation of DNMT3A on EMT. In the present study, we showed for the first time that DNMT3A promoted the Warburg effect, and crucial crosstalk between miR-145 and DNMT3A by a double-negative feedback loop.
In summary, the data indicate that, with its complementary structure, miR-145 combined with and thus negatively regulated DNMT3A.
DNMT3A also suppressed miR-145 through DNA methylation. The 
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